www.fdanews.com/articles/126746-glenmark-in-licensing-deal-with-us-company-for-cholesterol-drug
Glenmark in Licensing Deal With US Company for Cholesterol Drug
May 4, 2010
Drug firm Glenmark on Tuesday said it has signed an exclusive licensing agreement with the US-based Par Pharmaceutical to sell generic cholesterol-lowering
drug Ezetimibe in the US market.
The Economic Times
The Economic Times